Impact of Pre-Procedural Beta Blockade on Inpatient Mortality in Patients Undergoing Primary Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction
作者: Javier A. ValleMin ZhangSimon DixonHerbert D. AronowDavid ShareJoseph B. NaoumHitinder S. Gurm
作者单位: 1Division of Cardiology, University of Colorado School of Medicine, Denver, Colorado
2Department of Biostatistics, University of Michigan, Ann Arbor, Michigan
3Department of Family Medicine, University of Michigan, Ann Arbor, Michigan
4Department of Cardiovascular Medicine, William Beaumont Hospital, Royal Oak, Michigan
5Michigan Heart and Vascular Institute, St. Joseph Mercy Hospital, Ann Arbor, Michigan
6Department of Cardiology, Henry Ford Health Systems, Mt. Clemens, Michigan
7Division of Cardiovascular Medicine, University of Michigan Medical Center, Ann Arbor, Michigan
刊名: The American Journal of Cardiology, 2013, Vol.111 (12), pp.1714-1720
来源数据库: Elsevier Journal
DOI: 10.1016/j.amjcard.2013.02.022
英文摘要: Early use of β blockers (BBs) in acute myocardial infarction remains controversial, with some studies demonstrating benefit and others harm. The aim of this study was to assess the association between pre–percutaneous coronary intervention (PCI) BB use and in-hospital outcomes in patients who underwent primary PCI for ST-segment elevation myocardial infarction between 2007 and 2009 at institutions participating in the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC-2). Inverse propensity score weighting was used to account for the nonrandomized use of pre-PCI BBs. The cohort comprised 7,667 patients, with 4,769 (62%) receiving pre-PCI BBs. These patients were older, with higher rates of diabetes mellitus, hypertension, and previous myocardial infarction, PCI, or coronary...
全文获取路径: Elsevier  (合作)
影响因子:3.209 (2012)

  • Beta β